Uses of tranexamic acid and the risk of thrombosis in women: Number 11 – 2025

Venina Isabel Poço Viana Leme de Barros, Edimárlei Gonsales Valério, Marcelo Melzer Teruchkin · 2025

Read Uses of tranexamic acid and the risk of thrombosis in women: Number 11 – 2025 by Venina Isabel Poço Viana Leme de Barros, Edimárlei Gonsales Valério, Marcelo Melzer Teruchkin (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12713468.txt.

Description

Venina Leme de Barros and co-authors give clinical guidance on tranexamic acid for women in a 2025 recommendations paper. The drug slows the breakdown of blood clots, cutting bleeding and the deaths that follow from hemorrhage.

The guidance confirms its place in postpartum hemorrhage, childbirth's most dangerous bleed, and in heavy or abnormal uterine bleeding. On safety, the authors state that in general the drug does not raise the risk of venous clots. Still, women with added clot risks, such as birth control pill use or obesity, should be assessed one by one before taking it. The paper gives clinicians a compact, current rulebook for a cheap and widely available drug.

Catalog record

CREATORVenina Isabel Poço Viana Leme de Barros, Edimárlei Gonsales Valério, Marcelo Melzer Teruchkin
YEAR2025
COLLECTIONPAPERS
FORMATTXT
FILE SIZE17 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC12713468

Browse the full library · About the Tower of Babel